CN103073473B - 2‑对氟苄基‑3‑羟基吡咯烷氨基酸及其制备方法和抗癌活性研究 - Google Patents
2‑对氟苄基‑3‑羟基吡咯烷氨基酸及其制备方法和抗癌活性研究 Download PDFInfo
- Publication number
- CN103073473B CN103073473B CN201310014047.9A CN201310014047A CN103073473B CN 103073473 B CN103073473 B CN 103073473B CN 201310014047 A CN201310014047 A CN 201310014047A CN 103073473 B CN103073473 B CN 103073473B
- Authority
- CN
- China
- Prior art keywords
- compound
- preparation
- tertbutyloxycarbonyl protection
- acid amide
- final product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
化合物编号 | 化合物编号 | ||
1 | 4.5 | 5 | 3.8 |
2 | 12.3 | 6 | 5.9 |
3 | 8.9 | 7 | 8.8 |
4 | 6.4 | 8 | 20.2 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310014047.9A CN103073473B (zh) | 2013-01-15 | 2013-01-15 | 2‑对氟苄基‑3‑羟基吡咯烷氨基酸及其制备方法和抗癌活性研究 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310014047.9A CN103073473B (zh) | 2013-01-15 | 2013-01-15 | 2‑对氟苄基‑3‑羟基吡咯烷氨基酸及其制备方法和抗癌活性研究 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103073473A CN103073473A (zh) | 2013-05-01 |
CN103073473B true CN103073473B (zh) | 2017-06-23 |
Family
ID=48150194
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310014047.9A Active CN103073473B (zh) | 2013-01-15 | 2013-01-15 | 2‑对氟苄基‑3‑羟基吡咯烷氨基酸及其制备方法和抗癌活性研究 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103073473B (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101007800A (zh) * | 2006-01-26 | 2007-08-01 | 上海靶点药物有限公司 | 用于制备尼非韦罗的化合物及其制备方法 |
CN101497580A (zh) * | 2009-01-09 | 2009-08-05 | 华南理工大学 | Hiv-1抑制剂吡咯酮衍生物及其合成方法和应用 |
WO2010021878A1 (en) * | 2008-08-19 | 2010-02-25 | Janssen Pharmaceutica Nv | Cold menthol receptor antagonists |
CN101948418A (zh) * | 2010-08-06 | 2011-01-19 | 山东大学 | 含羟脯氨酸结构的hiv-1蛋白酶抑制剂及其制备方法与应用 |
US20110294827A1 (en) * | 2004-07-15 | 2011-12-01 | Tetralogic Pharmaceuticals Corporation | Iap binding compounds |
-
2013
- 2013-01-15 CN CN201310014047.9A patent/CN103073473B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110294827A1 (en) * | 2004-07-15 | 2011-12-01 | Tetralogic Pharmaceuticals Corporation | Iap binding compounds |
CN101007800A (zh) * | 2006-01-26 | 2007-08-01 | 上海靶点药物有限公司 | 用于制备尼非韦罗的化合物及其制备方法 |
WO2010021878A1 (en) * | 2008-08-19 | 2010-02-25 | Janssen Pharmaceutica Nv | Cold menthol receptor antagonists |
CN101497580A (zh) * | 2009-01-09 | 2009-08-05 | 华南理工大学 | Hiv-1抑制剂吡咯酮衍生物及其合成方法和应用 |
CN101948418A (zh) * | 2010-08-06 | 2011-01-19 | 山东大学 | 含羟脯氨酸结构的hiv-1蛋白酶抑制剂及其制备方法与应用 |
Also Published As
Publication number | Publication date |
---|---|
CN103073473A (zh) | 2013-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105153016B (zh) | 一种匹莫范色林的制备方法 | |
CN105820110B (zh) | 匹莫范色林合成方法 | |
CN101891647B (zh) | 一种乌苯美司的制备方法 | |
CN107522701B (zh) | 一种治疗慢性淋巴细胞白血病的BTK抑制剂Acalabrutinib的合成方法 | |
CN104557911B (zh) | 一种左旋吡喹酮的制备方法 | |
CN104945299A (zh) | 一种维格列汀的高效合成方法 | |
CN102180823B (zh) | 一种精制脯氨酰胺的方法 | |
CN108794491A (zh) | 一种枸橼酸托法替布的精制方法 | |
CN108586356A (zh) | 瑞博西尼新中间体及其制备瑞博西尼的合成方法 | |
ES2668477T3 (es) | Proceso de preparación de compuestos de aminoácidos | |
Tang et al. | Synthesis of a water-soluble cationic chiral diamine ligand bearing a diguanidinium and application in asymmetric transfer hydrogenation | |
CN105566215A (zh) | 一种瑞戈非尼的制备方法 | |
CN106008526B (zh) | 一种依鲁替尼的制备方法 | |
CN103204801A (zh) | N-Boc-3-哌啶酮的合成方法 | |
CN103641761A (zh) | 一种维格利汀的制备方法 | |
CN103073473B (zh) | 2‑对氟苄基‑3‑羟基吡咯烷氨基酸及其制备方法和抗癌活性研究 | |
CN102260210A (zh) | 蛋白激酶抑制剂和组蛋白去乙酰化酶抑制剂的萘酰胺衍生物的制备方法 | |
CN104447394A (zh) | 一种乌苯美司的新型合成工艺 | |
CN103467449B (zh) | 一种哌啶衍生物、制备方法及在制备常山酮中的应用 | |
CN104016877A (zh) | 一种苯基乙酰胺类化合物及在制备米拉贝隆中的应用 | |
CN102952134A (zh) | 含二氟甲基的金雀花碱衍生物及制备方法和抗癌作用研究 | |
CN103922986B (zh) | 维大列汀及其类似物、中间体及其制备方法和应用 | |
CN114341362B (zh) | 一种(r)-1,2,3,4-四氢异喹啉-1-羧酸及其衍生物和左旋吡喹酮的制备方法 | |
CN106117204B (zh) | 雷迪帕韦中间体(1R,3S,4S)‑2‑Boc‑2‑氮杂双环[2.2.1]戊烷‑3‑羧酸的制备方法 | |
CN108912032A (zh) | 一种(3s,4r)-4-甲基吡咯烷-3-基氨基甲醇叔丁酯盐酸盐的化学合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Owner name: TIANJIN YAOMING KANGDE NEW MEDICINE DEVELOPMENT CO Free format text: FORMER OWNER: TIANJIN YAOMING KANGDE NEW MEDICINE DEVELOPMENT CO., LTD. WUHAN YAOMING KANGDE NEW DRUGS DEVELOPMENT CO., LTD. YAOMINGKANGDE NEW MEDICINE DEVELOPMENT CO., LTD., WUXI SHANGHAI SYNTHEALL PHARMACEUTICAL CO., LTD. SHANGHAI STA PHARMACEUTICAL R + D CO., LTD. Effective date: 20141216 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20141216 Address after: 200131 Shanghai City, Pudong New Area Waigaoqiao Free Trade Zone Foote Road No. 288 Applicant after: Shanghai Yaoming Kangde New Medicine Development Co., Ltd. Applicant after: Tianjin Yaoming Kangde New Medicine Development Co., Ltd. Applicant after: Wuhan AppTec New Drug Development Co., Ltd. Address before: 200131 Shanghai City, Pudong New Area Waigaoqiao Free Trade Zone Foote Road No. 288 Applicant before: Shanghai Yaoming Kangde New Medicine Development Co., Ltd. Applicant before: Tianjin Yaoming Kangde New Medicine Development Co., Ltd. Applicant before: Wuhan AppTec New Drug Development Co., Ltd. Applicant before: Yaomingkangde New Medicine Development Co., Ltd., Wuxi Applicant before: Shanghai SynTheAll Pharmaceutical Co., Ltd. Applicant before: Shanghai STA Pharmaceutical R & D Co., Ltd. |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20170509 Address after: 300457 No. 111 Huang Hai Road, TEDA Development Zone, Tianjin, Tanggu Applicant after: Tianjin Yaoming Kangde New Medicine Development Co., Ltd. Address before: 200131 Shanghai City, Pudong New Area Waigaoqiao Free Trade Zone Foote Road No. 288 Applicant before: Shanghai Yaoming Kangde New Medicine Development Co., Ltd. Applicant before: Tianjin Yaoming Kangde New Medicine Development Co., Ltd. Applicant before: Wuhan AppTec New Drug Development Co., Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant |